FierceBiotech3d
FDA clears AngioDynamics’ NanoKnife pulsed field ablation system for prostate cancer
AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system, designed to precisely target ...
NanoKnife gains FDA clearance for prostate tissue ablation
AngioDynamics has won US Food and Drug Administration (FDA) clearance for its NanoKnife system to be used in prostate cancer ...
MassDevice4d
AngioDynamics wins FDA clearance for NanoKnife system in prostate tissue ablation
AngioDynamics received FDA 510(k) clearance for its NanoKnife system for prostate tissue ablation in intermediate-risk ...
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...
Morningstar5d
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
European Union: The NanoKnife System is indicated for the ablation of prostate tissue in patients with intermediate risk prostate cancer. About AngioDynamics, Inc. AngioDynamics is a leading and ...
Stockhouse4d
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
1 The study’s results validated the robust safety and clinical efficacy profile of the NanoKnife System, reinforcing findings from more than 32 clinical studies performed around the ...
AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife
Shares of AngioDynamics hit a 52-week high after the company's NanoKnife System for prostate tissue ablation received regulatory clearance. The stock jumped almost 35% to a high of $9.42 in early ...